Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of gabapentin on urinary catheter discomfort in EVAR-treated AAA patients
2009-013036-20Phase 4Terminated
- Sponsor
- Rigshospitalet
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of gabapentin in abdominal aortic aneurysm (AAA), sponsored by Rigshospitalet. Primary endpoint: Urinary catheter-related discomfort in recovery ward (POTA). Started Aug 2009; status: terminated.
02
Drugs
gabapentin
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on 2009-013036-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013036-20.